AstraZeneca
AZN
AZN
1,012 hedge funds and large institutions have $34.8B invested in AstraZeneca in 2022 Q2 according to their latest regulatory filings, with 113 funds opening new positions, 310 increasing their positions, 354 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,012
Holders Change
+34
Holders Change %
+3.48%
% of All Funds
17.11%
Holding in Top 10
24
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+41.18%
% of All Funds
0.41%
New
113
Increased
310
Reduced
354
Closed
68
Calls
$386M
Puts
$457M
Net Calls
-$70.8M
Net Calls Change
-$115M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$550M |
| 2 |
Morgan Stanley
New York
|
+$349M |
| 3 |
BlackRock
New York
|
+$295M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$158M |
| 5 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$116M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$549M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$195M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$102M |
| 4 |
SIG
Senator Investment Group
New York
|
-$99.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$88.9M |
